Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- POPPiIndependent statistical analysis of Improving Uptake and Adherence to HIV Prevention Services With Pre-exposure Prophylaxis (PrEP), HIV Self- Testing and Adherence Support for Very High Risk HIV-negative Young Women Aged 15-24 in…
- PoPPSIndependent statistical analysis of Prevention of Preterm Birth With a Pessary in Singleton Gestations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02056652).
- PopSeqIndependent statistical analysis of Return of Genomic Results and Aggregate Penetrance in Population-Based Cohorts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04196374).
- PopSole2Independent statistical analysis of Validation of a Novel Foot Offloading Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04378270).
- Porfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Porfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer: primary endpoint results, effect…
- Portico and Navitor India Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Portico and Navitor India Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05171712).
- PORTICO-1Independent statistical analysis of 5 Year Observation of Patients With PORTICO Valves: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01802788).
- Portion Control Treatment for Obesity: Complete Statistical AnalysisIndependent statistical analysis of Portion Control Treatment for Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01451554).
- PortionSize Study 2 Free-Living Evaluation: Complete Statistical AnalysisIndependent statistical analysis of PortionSize Study 2 Free-Living Evaluation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05166226).
- PortionSize Study 3: Assessment in Free-living Conditions: Complete Statistical AnalysisIndependent statistical analysis of PortionSize Study 3: Assessment in Free-living Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05906160).
- PortionSizeAIIndependent statistical analysis of Validity of an AI-based Program to Identify Foods and Estimate Food Portion Size: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PORTLinkIndependent statistical analysis of PORTuguese Research on Telemonitoring With CareLink® (PORTLink): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03125382).
- POSAIndependent statistical analysis of Single Dose Population Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- POSA-FLUIndependent statistical analysis of Posaconazole for the Prevention of Influenza-associated Aspergillosis in Critically Ill Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients: Complete Statistical AnalysisIndependent statistical analysis of Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03318159).
- POSEIDONIndependent statistical analysis of Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01313273).
- POSIBAIndependent statistical analysis of Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Positive Activities for Asian American Cancer Patients and Caregivers: Complete Statistical AnalysisIndependent statistical analysis of Positive Activities for Asian American Cancer Patients and Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05203614).
- POSITIVE Stroke Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of POSITIVE Stroke Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01852201).
- Positive Youth Development in the Metaverse: Complete Statistical AnalysisIndependent statistical analysis of Positive Youth Development in the Metaverse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05858593).
- Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels: Complete Statistical AnalysisIndependent statistical analysis of Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00924313).
- Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Positron Emission Tomography Study in Healthy Subjects to Determine the Relationship Between Plasma Concentration and Brain Target Occupancy of ASN51: Complete Statistical AnalysisIndependent statistical analysis of Positron Emission Tomography Study in Healthy Subjects to Determine the Relationship Between Plasma Concentration and Brain Target Occupancy of ASN51: primary endpoint results, effect estimate with confidence interval,…
- Post Approval Study of the AcrySof® IQ ReSTOR® Toric IOLs: Complete Statistical AnalysisIndependent statistical analysis of Post Approval Study of the AcrySof® IQ ReSTOR® Toric IOLs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03733730).
- Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data: Complete Statistical AnalysisIndependent statistical analysis of Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Post Market Clinical Follow-Up of the Zimmer Stafit Acetabular System: Complete Statistical AnalysisIndependent statistical analysis of Post Market Clinical Follow-Up of the Zimmer Stafit Acetabular System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04079114).
- Post Market Evaluation of Aer-O-Scope Visualization: Complete Statistical AnalysisIndependent statistical analysis of Post Market Evaluation of Aer-O-Scope Visualization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02926209).
- Post Market Study of the InnFocus MicroShunt: Complete Statistical AnalysisIndependent statistical analysis of Post Market Study of the InnFocus MicroShunt: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02177123).
- Post Market Study Using the Xoft Axxent System: Complete Statistical AnalysisIndependent statistical analysis of Post Market Study Using the Xoft Axxent System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01017549).
- Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO): Complete Statistical AnalysisIndependent statistical analysis of Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Post Marketing Study in Subjects Who Have Type 2 Diabetes Using the EndoBarrier™ Gastrointestinal Liner: Complete Statistical AnalysisIndependent statistical analysis of Post Marketing Study in Subjects Who Have Type 2 Diabetes Using the EndoBarrier™ Gastrointestinal Liner: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Post Marketing Surveillance (PMS) of JARDIANCE in Chronic Heart Failure (CHF): Complete Statistical AnalysisIndependent statistical analysis of Post Marketing Surveillance (PMS) of JARDIANCE in Chronic Heart Failure (CHF): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Post Marketing Surveillance For General Drug Use To Assess the Safety And Efficacy Profile Of Viviant In Usual Practice: Complete Statistical AnalysisIndependent statistical analysis of Post Marketing Surveillance For General Drug Use To Assess the Safety And Efficacy Profile Of Viviant In Usual Practice: primary endpoint results, effect estimate with confidence interval, sample-size…
- Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder: Complete Statistical AnalysisIndependent statistical analysis of Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Post Marketing Surveillance Study for Evaluation of Efficacy and Safety of Dotarem in Magnetic Resonance Mammography: Complete Statistical AnalysisIndependent statistical analysis of Post Marketing Surveillance Study for Evaluation of Efficacy and Safety of Dotarem in Magnetic Resonance Mammography: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Post Marketing Surveillance To Observe Safety And Efficacy Of Duavive: Complete Statistical AnalysisIndependent statistical analysis of Post Marketing Surveillance To Observe Safety And Efficacy Of Duavive: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02792504).
- Post Marketing Surveillance To Observe Safety And Efficacy Of Xyntha® In Subjects With Hemophilia A: Complete Statistical AnalysisIndependent statistical analysis of Post Marketing Surveillance To Observe Safety And Efficacy Of Xyntha® In Subjects With Hemophilia A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Post Operative Sore Throat and Dexamethasone: Complete Statistical AnalysisIndependent statistical analysis of Post Operative Sore Throat and Dexamethasone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01052038).
- Post Transplant Donor Lymphocyte Infusion: Complete Statistical AnalysisIndependent statistical analysis of Post Transplant Donor Lymphocyte Infusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00167180).
- Post Treatment Comparison Intramedullary Nail vs. Nonoperative Treatment: Complete Statistical AnalysisIndependent statistical analysis of Post Treatment Comparison Intramedullary Nail vs. Nonoperative Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01975467).
- Post-Approval Study Protocol for the Simplify Cervical Artificial Disc: Complete Statistical AnalysisIndependent statistical analysis of Post-Approval Study Protocol for the Simplify Cervical Artificial Disc: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04630626).
- Post-Approval Study Protocol of the St. Jude Medical Trifecta Valve: Complete Statistical AnalysisIndependent statistical analysis of Post-Approval Study Protocol of the St. Jude Medical Trifecta Valve: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01514162).
- Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Complete Statistical AnalysisIndependent statistical analysis of Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02893878).
- Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England: Complete Statistical AnalysisIndependent statistical analysis of Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Post-authorization Safety Study in Type 2 Diabetic Patients in Saudi Arabia Treated With Empagliflozin to Assess the Incidence of Ketoacidosis, Severe Complications of Urinary Tract Infection, Volume Depletion, and Dehydration: Complete Statistical AnalysisIndependent statistical analysis of Post-authorization Safety Study in Type 2 Diabetic Patients in Saudi Arabia Treated With Empagliflozin to Assess the Incidence of Ketoacidosis, Severe Complications of Urinary Tract Infection, Volume Depletion,…
- Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD Subjects: Complete Statistical AnalysisIndependent statistical analysis of Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Post-chemotherapy Symptom Management SMART: Complete Statistical AnalysisIndependent statistical analysis of Post-chemotherapy Symptom Management SMART: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03494166).
- Post-licensure Safety Study of IMOJEV® in Thailand: Complete Statistical AnalysisIndependent statistical analysis of Post-licensure Safety Study of IMOJEV® in Thailand: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01981967).
- Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®: Complete Statistical AnalysisIndependent statistical analysis of Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…